Abstract:BACKGROUND: Vascular endothelial growth factor (VEGF) can specifically promote the division and proliferation of endothelial cells and the revascularization, finally induce angiopoiesis. Recently, VEGF-based gene therapy has been gradually used in clinical trials, but some limits on usually used vectors deserve further studies, including the low transfection efficiency of plasmid vector, the immunogenicity of adnovirus vector to host cells and the potential risk of infection. OBJECTIVE: To construct the non-pathogenic recombinant adeno-associated vires (AAV) co-expressing human vascular endethelial growth factor 165 (hVEGF165) and green fluorescent protein (GFP) label and measure the virus titer and assess its biological activity.DESIGN, TIME AND SETTING: The open experiment was performed at the Vitrus Laboratory of Shanxi Provincial Center for Disease Control and Prevention from March to September 2007.MATERIALS: AAV-293 virus packaging cell line, AAV HT-1080 cells were purchased from Swatagene, USA. E.coli DH5α was a stocked strain from Shanxi Provincial Center for Disease Control and Prevention. AAV Helper Free System (pAAV-IRES-GFP vector containing GFP label) was purchased from Stratagene, USA. Plasmid pUC18-hVEGF165 was constructed previously by Dr.Shi from Department of Orthopaedics of Second Affiliated Hospital of Xi'an Jiaotong University.METHODS: The hVEGF165 gone from plasmid pUC18-hVEGF165 was amplified and inserted into plasmid pAAV-IRES-hrGFP. Then recombinant plasmid pAAV-hVEGF165-IRES-hrGFP, pAAV-RC and pAAV-Helper were co-transfected into AAV-293 cells to complete rAAV-hVEGF165-IRES-hrGFP packaging through homologous recombination. The efficiency of A.AV packaging was monitored under a fluorescent microscope, and the recombinant viral particles were harvested from infected AAV-293 cells and further concentrated and purified. The recombinant virus infected the AAV-HT1080 cells, the virus titer was measured by fluorescence counting, and the recombinant AAV-hVEGF165-IRES-hrGFP was verified by the amplification of the exogenous gene of hVEGF165 from virus genome.MAIN OUTCOME MEASURES: Virus packaging efficiency was monitored under the fluorescence microscope. Virus filer was measured by fluorescent counting. The packaging of recombinant virus was determined by the amplification of the exogenous hVEGF165 gene.RESULTS: The amplified products were verified as hVEGF165 gene by DNA sequencing, and the recombinant pAAV-hVEGF165-IRES-hrGFP was confirmed by double digestion. The system provided a high packaging ratio of over 95% and the purified recombinant virus had a high titer of 5.5×1011 vp/mL. The recombinant virus was confirmed by exogenous human VEGF165 gene from virus genome.CONCLUSION: The non-pathogenic rAAV-hVEGF165-GFP simultaneously carrying hVEGF165 and GFP 1abel is successfully constructed, with a high titer and satisfying biological activity.

Preparation of recombinant adenovirus vector containing human HIF-1 and infective evaluation of the adenovirus on epidermal keratinocytes

Enhanced Growth of Recombinant Human Adenovirus Type 41 (Hadv-41) Carrying ADP Gene

Study on Inhibitation of the Tube Formation by RNA Introduced by Adenovirus by its Interference With and Decrease of VEGF Transcription

Construction of Recombinant Adenovirus of hAIF-1 Gene and Its Effect on Proliferation and Migration of A549 Cells

[Construction of Recombinant Adenovirus Vector of Mouse Keratinocyte Growth Factor].

Construction of the Recombinant Adenovirus RNA Interference Vector of Human Hypoxia-Inducible Transcription Factor-1Α Gene and Its Effect on Expression of HIF-1α Gene in Human Lung Adenocarcinoma Cells SPCA-1

Construction of Replication-Deficient Recombinant Adenovirus Vector with Htfpi-2 Gene by Admax System and Expression in U937 Monocytes in Vitro

Construction of a recombinant adenovirus vector containing MIF and its expression in human airway smooth muscle cells

Construction of Recombinant Adenoviruses Carrying Human Hepatocyte Growth Factor and Investigation of Its Effect on Human Fetal Hepatocytes in Vitro

Construction of Adenovirus Vector with Human Interleukin 10 and Its Expression in Vascular Smooth Muscle Cells

Construction of Recombinant Adenovirus Encoding mIκBα and the Suppression of Angiogenesis in Vitro

Construction of Recombinant Adenovirus Vector Containing Human Survivin Gene and Expression in Fibroblast

Construction and Target Gene Expression of Recombinant Adenovirus Vectors Containing Vascular Endothelial Growth Factor 165 and Angiopoietin-1

Construction and Identification of Recombinant Adeno- Associated Virus Vector Co-Expressing Human Vascular Endothelial Growth Factor and Green Fluorescent Protein

Transfection of adenovirus containing hepatocyte growth factor gene into adipose tissue-derived stromal cells

Recombinant Hfgf-10 Adenovirus Promotes Proliferation of Kerotinocytes

Construction and functional identification of rat Hes1 adenovirus expression vector

Cloning and Construction of Adenovirus Expressing Human Angiopoietin-1 or Vascular Endothelial Growth Factor

Construction of the Recombinant Human Endothelial Nitric Oxide Synthase Gene Adenovirus and Its Expression in Human Vascular Smooth Muscle Cells

Establishment of A Recombinant Adeno-Associated Virus Expressing Hvegf(165)

Construction and identification of green fluorescent protein labeled recombinant adenovirus containing human vascular endothelial growth factor 165 gene